{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T04:10:39Z","timestamp":1730434239634,"version":"3.28.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>There are two distinct kinetic functional pharmacological procedures by which the equilibrium affinity constant, KB, of a competitive reversible blocker is obtained. The classical method on an organ system requires the study of the parallel displacement of the agonist concentration-response curve in the presence of the blocker. In the second method, the agonist-evoked functional mechanical response is reduced to half by the blocker IC50 (the concentration required for 50% inhibition). In relation to these parameters the role of the ionization constant pKa and liposolubility log Pc or log D of blockers was examined. On the ciliary muscle from human eye, IC50\/KB ratios for (\u00b1)-atropine, its quaternary analogue (\u00b1)-methylatropine, (-)-scopolamine, (\u00b1)-cyclopentolate, (-)-tropicamide, (\u00b1)-oxybutynin and pirenzepine were 15, 23, 4.4, 2.6, 1.66, 1.46 and 1.71, respectively. The ratios on the iris sphincter were comparable with those of ciliary muscle. When compared with large proportions of ionized molecules with water soluble properties of (\u00b1)-atropine and (\u00b1)-methylatropine, relatively high amounts of un-ionized and\/or with greater partitioning of all other blockers in the lipoid barrier co-related well to low IC50\/KB ratios, as predicted by the classical theory of competitive drug antagonism. It was hypothesized that due to receptor biophase access, the reduction of the mechanical response of the agonist by the highly ionized water-soluble antagonist at IC50 represented time-distorted \u201cpseudo-equilibrium\u201d estimation, where a higher concentration of the blocker was needed. On the other cholinergic effectors, like that of rat anococcygeus muscle or frog rectus abdominus muscle, IC50\/KB ratios of respective blockers atropine or (+)-tubocurarine and hexamethonium were close to 1. Thus physicochemical properties, which affect the distribution coefficient log D and the tissue morphology (where asymmetric distribution of receptors may occur), appeared to be a critical factor in the analysis of the affinity parameters of the competitive reversible blocker. On the intraocular muscles, two functional pharmacological procedures for obtaining KB and IC50 values were not kinetically equivalent.<\/jats:p>","DOI":"10.1211\/0022357043978","type":"journal-article","created":{"date-parts":[[2004,7,19]],"date-time":"2004-07-19T21:51:54Z","timestamp":1090273914000},"page":"1045-1053","source":"Crossref","is-referenced-by-count":4,"title":["Parameters of drug antagonism: re-examination of two modes of functional competitive drug antagonism on intraocular muscles"],"prefix":"10.1093","volume":"56","author":[{"given":"Popat N","family":"Patil","sequence":"first","affiliation":[{"name":"The Ohio State University, Division of Pharmacology, College of Pharmacy (LM Parks Hall) , 500 W. 12 th Avenue, Columbus, OH 43210,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2004,8,1]]},"reference":[{"key":"2024103109402393200_cit1","first-page":"32","article-title":"Affinity and intrinsic activity in the theory of competitive inhibition Part I. Problems and theory","volume":"99","author":"Ari\u00ebns","year":"1954","journal-title":"Arch. Int. Pharmacodyn."},{"key":"2024103109402393200_cit2","first-page":"48","article-title":"Some quantitative uses of drug antagonists","volume":"14","author":"Arunlakshana","year":"1959","journal-title":"Br. J. Pharmacol."},{"key":"2024103109402393200_cit3","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0165-6147(00)89042-2","article-title":"Use of antagonist for estimating the degree of agonist stimulation during physiological release","volume":"16","author":"Barlow","year":"1995","journal-title":"Trends Pharmacol. Sci."},{"key":"2024103109402393200_cit4","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1476-5381.1982.tb09331.x","article-title":"The effects of pH on the affinity of pirenzepine for muscarinic receptors in the guinea pig ileum and rat fundus strip","volume":"77","author":"Barlow","year":"1982","journal-title":"Br. J. Pharmacol."},{"key":"2024103109402393200_cit5","first-page":"39","volume-title":"Textbook of pharmacology","author":"Bowman","year":"1980","edition":"2nd edn"},{"key":"2024103109402393200_cit6","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (Ki) and the concentration which causes 50 percent inhibition IC50 of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"2024103109402393200_cit7","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/sj.bjp.0702164","article-title":"Binding, gating, affinity and efficacy: the interpretation of structure activity relationships for agonists and effects of mutating receptors","volume":"125","author":"Colquhoun","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"2024103109402393200_cit8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0024-3205(89)90221-X","article-title":"Problems associated with the application of the Cheng-Prusoff relationship to estimate atropine affinity constants using functional tissue responses","volume":"44","author":"Eglen","year":"1989","journal-title":"Life Sci."},{"key":"2024103109402393200_cit9","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.2042-7158.1988.tb05319.x","article-title":"Influence of liposolubility and chirality on the selectivity of ligands for \u03b21- and \u03b22-adrenoceptors","volume":"40","author":"El Tayar","year":"1988","journal-title":"J. Pharm. Pharmacol."},{"key":"2024103109402393200_cit10","volume-title":"Principles of medicinal chemistry","author":"Foye","year":"1995","edition":"4th edn"},{"key":"2024103109402393200_cit11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev.pa.04.040164.000321","article-title":"Receptor mechanisms","volume":"4","author":"Furchgott","year":"1964","journal-title":"Ann. Rev. Pharmacol."},{"key":"2024103109402393200_cit12","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1749-6632.1967.tb41229.x","article-title":"The pharmacological differentiation of adrenergic receptors","volume":"139","author":"Furchgott","year":"1967","journal-title":"Ann. NY Acad. Sci."},{"key":"2024103109402393200_cit13","first-page":"283","article-title":"The classification of adrenoceptors (adrenergic receptors): an evaluation from standpoint of receptor theory","volume-title":"Catecholamines. Handbook of experimental pharmacology","author":"Furchgott","year":"1972"},{"key":"2024103109402393200_cit14","first-page":"7P","article-title":"The quantitative effects of antagonistic drugs","author":"Gaddum","year":"1937","journal-title":"J. Physiol. (London)"},{"key":"2024103109402393200_cit15","first-page":"211","article-title":"Drug antagonism","volume":"9","author":"Gaddum","year":"1957","journal-title":"Pharmacol. Rev."},{"key":"2024103109402393200_cit16","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1476-5381.1972.tb08097.x","article-title":"The rat anococcygeus muscle and its response to nerve stimulation and to some drugs","volume":"45","author":"Gillespie","year":"1972","journal-title":"Br. J. Pharmacol."},{"volume-title":"Comprehensive medicinal chemistry","year":"1990","author":"Hansch","key":"2024103109402393200_cit17"},{"key":"2024103109402393200_cit18","first-page":"97","volume-title":"Exploring QSAR","author":"Hansch","year":"1995"},{"key":"2024103109402393200_cit19","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/jop.1998.14.363","article-title":"Selectivity of muscarinic agonists including (\u00b1)-aceclidine and antimuscarinics on the human intraocular muscles","volume":"14","author":"Ishikawa","year":"1998","journal-title":"J. Ocular Pharmacol. Ther."},{"key":"2024103109402393200_cit20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-3-642-78920-5_3","article-title":"Excitation-contraction coupling mechanisms in visceral smooth muscle cells","volume-title":"Pharmacology of smooth muscle. Handbook of experimental pharmacology","author":"Itoh","year":"1994"},{"key":"2024103109402393200_cit21","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1016\/S0021-9258(19)85782-4","article-title":"Kinetic studies on muscarinic antagonist-agonist competition","volume":"255","author":"Jarv","year":"1980","journal-title":"J. Biol. Chem."},{"key":"2024103109402393200_cit22","volume-title":"Pharmacologic analysis of drug-receptor interaction","author":"Kenakin","year":"1993","edition":"2nd edn"},{"key":"2024103109402393200_cit23","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev.pharmtox.42.091401.113012","article-title":"Drug efficacy at G protein-coupled receptors","volume":"42","author":"Kenakin","year":"2002","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"2024103109402393200_cit24","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.1476-5381.1993.tb13737.x","article-title":"Estimation of competitive antagonist affinity from inhibition curves using the Gaddum, Schild and Cheng-Prusoff equation","volume":"109","author":"Lazareno","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"2024103109402393200_cit25","first-page":"1","article-title":"The kinetics of competitive radioligand binding predicted by the law of mass action","volume":"25","author":"Motulsky","year":"1984","journal-title":"Mol. Pharmacol."},{"key":"2024103109402393200_cit26","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1124\/mol.61.3.473","article-title":"New determinants of receptor-effector coupling: trafficking and compartmentation in membrane microdomains","volume":"61","author":"Ostrum","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"2024103109402393200_cit27","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/BF00168733","article-title":"Reactivity of human iris sphincter to muscarinic drugs in vitro","volume":"346","author":"Patil","year":"1992","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"2024103109402393200_cit28","first-page":"615","article-title":"Pharmacologic quantitation","volume":"34","author":"Patil","year":"1996","journal-title":"Indian J. Exp. Biol."},{"key":"2024103109402393200_cit29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/jop.1999.15.65","article-title":"Enhanced sensitivity of the iris sphincter to the muscarinic agonist carbachol at lower temperature","volume":"15","author":"Patil","year":"1999","journal-title":"J. Ocular Pharmacol. Ther."},{"key":"2024103109402393200_cit30","first-page":"579","article-title":"Reversal of cholinergic response of intraocular muscles by atropine: drug antagonism re-examined","volume-title":"Pharmacology and therapeutics in the new millennium","author":"Patil","year":"2001"},{"volume-title":"Two processes of competitive drug antagonism","year":"2002","author":"Patil","key":"2024103109402393200_cit31"},{"key":"2024103109402393200_cit32","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/BF00168734","article-title":"Cholinergic sensitivity of irides from donors with various pathological conditions and lens implants","volume":"346","author":"Patil","year":"1992","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"2024103109402393200_cit33","first-page":"152","article-title":"The active structure of local anesthetics","volume":"150","author":"Ritchie","year":"1965","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2024103109402393200_cit34","first-page":"79","article-title":"Iris pigmentation and atropine mydriasis","volume":"197","author":"Salazar","year":"1976","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2024103109402393200_cit35","first-page":"189","article-title":"pA, a new scale for the measurement of drug antagonism","volume":"2","author":"Schild","year":"1947","journal-title":"Br. J. Pharmacol."},{"key":"2024103109402393200_cit36","first-page":"251","article-title":"The use of drug antagonist for the identification and classification of drugs","volume":"2","author":"Schild","year":"1947","journal-title":"Br. J. Pharmacol."},{"volume-title":"Pharmacological experiments on isolated preparations","year":"1968","author":"The Staff","key":"2024103109402393200_cit37"},{"key":"2024103109402393200_cit38","first-page":"240","article-title":"Cumulative dose-response curves. I Introduction to the technique","volume":"143","author":"Van Rossum","year":"1963","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"2024103109402393200_cit39","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/0024-3205(78)90096-6","article-title":"Kinetic and empirical analysis of dose-response curves illustrated with a cardiac example","volume":"22","author":"Waud","year":"1978","journal-title":"Life Sci."}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1211%2F0022357043978","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/56\/8\/1045\/60260391\/0022357043978.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/56\/8\/1045\/60260391\/0022357043978.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T10:16:08Z","timestamp":1730369768000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/56\/8\/1045\/6147334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8,1]]},"references-count":39,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2004,8,1]]},"published-print":{"date-parts":[[2004,8,1]]}},"URL":"https:\/\/doi.org\/10.1211\/0022357043978","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"type":"print","value":"0022-3573"},{"type":"electronic","value":"2042-7158"}],"subject":[],"published-other":{"date-parts":[[2004,8]]},"published":{"date-parts":[[2004,8,1]]}}}